Integrated Medicament Injection Pen for Continuous Glucose Monitoring
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional self-monitoring blood glucose (SMBG) methods are inconvenient and infrequent, leading to delayed detection of hyper- or hypo-glycemic conditions, and require user discipline and education to minimize dangerous situations.
Innovation Solution
An integrated system combining a medicament injection pen and a continuous glucose sensor, with electronics to process sensor data and calculate therapy, providing real-time glucose monitoring and medicament delivery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Loss of time
If conventional self-monitoring blood glucose (SMBG) methods are used, then the device complexity is low, but the monitoring frequency is insufficient and detection timeliness is delayed
Solution Approach 1:
The patent combines the continuous glucose sensor, receiver with processing electronics, and medicament injection pen into an integrated system. The sensor continuously monitors glucose levels and transmits data to the receiver, which processes the information and communicates dosing recommendations to the injection pen, enabling timely detection and response without requiring multiple separate devices
Solution Approach 2:
The integrated receiver serves multiple functions: receiving sensor data, processing glucose concentration information, calculating medicament dosing, and communicating with the injection pen. This multi-functional approach reduces the need for separate monitoring and treatment devices, improving detection timeliness while managing system complexity
2Reliability
If conventional SMBG methods are used, then the ease of operation is moderate, but user discipline and education are required to minimize errors
Solution Approach 1:
The system performs automatic glucose monitoring without requiring user initiation of each measurement. The sensor continuously measures glucose levels and the receiver automatically processes the data and generates dosing recommendations, reducing reliance on user discipline and minimizing opportunities for user error while maintaining ease of operation
Solution Approach 2:
The system provides continuous feedback through the integration of sensor data processing and automatic dosing recommendations. The receiver analyzes glucose trends and communicates precise medicament dosing instructions to the injection pen, creating a closed-loop system that reduces user error by providing real-time guidance based on actual glucose levels
3Measurement precision
If integrated system with real-time monitoring is implemented, then the detection precision is improved, but the device complexity increases
Solution Approach 1:
The integrated system is divided into distinct functional modules: the continuous glucose sensor for precise measurement, the receiver with processing electronics for data analysis, and the medicament injection pen for treatment delivery. This segmentation allows each component to be optimized for its specific function while working together as an integrated system, improving measurement precision without overwhelming complexity
Data Source
AI summary
An integrated system for the monitoring and treating diabetes is provided, including an integrated receiver/hand-held medicament injection pen, including electronics, for use with a continuous glucose sensor. In some embodiments, the receiver is configured to receive continuous glucose sensor data, to calculate a medicament therapy (e.g., via the integrated system electronics) and to automatically set a bolus dose of the integrated hand-held medicament injection pen, whereby the user can manually inject the bolus dose of medicament into the host. In some embodiments, the integrated receiver and hand-held medicament injection pen are integrally formed, while in other embodiments they are detachably connected and communicated via mutually engaging electrical contacts and/or via wireless communication.